Item 1.01 Entry into a Material Definitive Agreement.

On May 23, 2017, Anu Life Sciences, Inc. (“ Anu ”), a Florida corporation and a wholly-owned subsidiary of Biotech Products Services and Research, Inc., a Nevada corporation (the “ Company ”), entered into that certain lease agreement (the “ Lease ”) with Sunwest Office Park, LLC a Florida limited liability company (the “ Landlord ”), pursuant to which Anu has agreed to lease Bay 408 of Building D located at 15481 SW 12 Street, Sunrise, FL 33326 consisting of approximately 3,500 square feet (the “ Leased Premises ”) for the “permitted use,” defined in the Lease office, laboratory, research, processing, manufacturing, storage and distribution of biologics and other human tissue derived products and for no other purpose. The term of the Lease is five years, commencing on July 1, 2017, for $66,395.00 of minimum rent in year 1 to $90,579.96 of minimum rent in year 5 and annual adjustments of Anu’s proportionate share of operating expenses, including real estate taxes. Anu has two (2) options to renew the Lease of five (5) years each with rental rates in the option term to increase 3% per annum.

Anu may not assign the Lease or sublet the Leased Premises in whole or in part without Landlord's prior written consent. In the event of any permitted assignment or subletting, Anu shall remain primarily liable under the Lase, and any extension, expansion, rights of first offer, rights of first refusal or other options granted to Anu under this Lease shall be rendered void and of no further force or effect. The acceptance of rent from any other person shall not be deemed to be a waiver of any of the provisions of this Lease or to be a consent to the assignment of this Lease or the subletting of the Leased Premises.

Notwithstanding anything to the contrary contained in the foregoing paragraph, Anu shall have the right, without Landlord's consent, but upon ten (10) days prior notice to Landlord, to (a) sublet all or part of the Leased Premises to any related corporation or other entity which controls Anu, is controlled by Anu or is under common control with Anu; (b) assign all or any part of the Lease to any related corporation or other entity which controls Anu, is controlled by Anu, or is under common control with Anu, or to a successor entity into which or with which Anu is merged or consolidated or which acquires substantially all of Anu's assets or property; or (c) effectuate any public offering of Anu's stock on the New York Stock Exchange or in the NASDAQ over the counter market, provided that in the event of a transfer pursuant to clause (b), the tangible net worth after any such transaction is not less than the tangible net worth of Anu as of the date hereof and provided further that such successor entity assumes all of the obligations and liabilities of Anu (any such entity hereinafter referred to as a "Permitted Transferee"). For the purpose of the foregoing, (i) "control" shall mean ownership of not less than fifty percent (50%) of all voting stock or legal and equitable interest in such corporation or entity, and (ii) "tangible net worth" shall mean the excess of the value of tangible assets (i.e. assets excluding those which are intangible such as goodwill, patents and trademarks) over liabilities. Any such transfer shall not relieve Anu of its obligations under the Lease.

The Lease contained customary mutual indemnification clauses.

A copy of the Lease is filed as an exhibit to this Form 8-K and is incorporated by reference herein.